Alendronate

InterventionApproved 19953 papers2 findingsPubChem 2088ChEBI 2567

  • Animals2

Outcomes

2

CASP9

downin rats1Very low certainty

1 study
  1. Alendronate decreases CASP9 in rats.

    Animalsovariectomyoral gavagefemur5 μg/kg/day10 weeksfemales

    Comparison of Naringenin and Alendronate in the Attenuation of Ovariectomy-Induced Osteoporosis by Modulating Autophagy, Apoptosis, and Oxidative Stress in Rats · Iranian journal of pharmaceutical research : IJPR · 13 Jun 2026

CASP9 →

Femoral stereological/histomorphometric outcomes

upin rats1Very low certainty

1 study
  1. Alendronate improves femoral stereological/histomorphometric outcomes in rats.

    Animalsovariectomyoral gavagebone5 μg/kg/day10 weeksfemales

    Comparison of Naringenin and Alendronate in the Attenuation of Ovariectomy-Induced Osteoporosis by Modulating Autophagy, Apoptosis, and Oxidative Stress in Rats · Iranian journal of pharmaceutical research : IJPR · 13 Jun 2026

Trials

75

Approved

Repurposing

All 26

In trials

  • Metabolic bone disease

    Phase 4 · Completed · 13 trials

  • Bone Resorption

    Phase 4 · Completed · 3 trials

  • Osteonecrosis

    Phase 4 · Status unknown · 2 trials

  • Primary hyperparathyroidism

    Phase 4 · Completed · 1 trial

  • Breast Neoplasms

    Phase 3 · Completed · 3 trials

  • Prostatic Neoplasms

    Phase 3 · Completed · 3 trials

All 9
  • Rare Diseases

    Phase 2 · Results posted · 2 trials

  • Spinal Cord Diseases

    Phase 2 · Results posted · 2 trials

  • Central nervous system disease

    Phase 2 · Results posted · 1 trial

Readouts due

Trial sponsors

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 2Sep 2026: 1Oct 2026: 15